What is the most common cause of skeletal abnormality in a case of renal osteodystrophy?
A 14-year-old boy develops nephrotic syndrome. A renal biopsy shows foot process fusion and no deposits on the membranes under electron microscopy. Which of the following is the most likely diagnosis?
Eosinophiluria is typically seen in which of the following conditions?
A patient presents with the clinical triad of nephritis, hematuria, and hemoptysis, along with the presence of antinuclear membrane antibodies. What is the likely diagnosis?
Which of the following statements is not true regarding IgA nephropathy (Berger's disease)?
A 35-year-old man with AML and WBC of 100,000 cells/µL is treated with chemotherapy and develops oliguric renal failure. His urine is acidic and numerous crystals are noted in the urine. What is the most likely diagnosis?
Amyloidosis of the kidney may be seen in which of the following conditions, except?
Which of the following is seen in nephrotic syndrome?
What is true about Hemolytic Uremic Syndrome (HUS)?
Which chromosomal mutation is characteristic of low-grade transitional cell carcinoma of the bladder?
Explanation: **Explanation:** Renal osteodystrophy refers to the spectrum of skeletal changes occurring in chronic kidney disease (CKD). The central driver and **most common initiating cause** of this pathology is **Hyperphosphatemia**. [1] **Why Hyperphosphatemia is the correct answer:** In CKD, the declining Glomerular Filtration Rate (GFR) leads to phosphate retention. This elevated serum phosphate triggers a cascade: 1. It directly stimulates the secretion of **FGF-23** and **Parathyroid Hormone (PTH)**. [1] 2. It causes **hypocalcemia** by binding to free ionized calcium (precipitation). [2] 3. It inhibits the enzyme **1-alpha-hydroxylase**, further reducing Vitamin D activation. [3] The resulting secondary hyperparathyroidism leads to increased osteoclast activity (Osteitis fibrosa cystica), making phosphate retention the primary metabolic trigger. [2] **Analysis of Incorrect Options:** * **A. Impaired synthesis of Vitamin D3:** While this occurs due to loss of renal parenchyma and inhibition by FGF-23/phosphate, it is a *consequence* of the metabolic derangement rather than the primary driver of the PTH surge. [1] * **B. Hypocalcemia:** This is a major stimulus for PTH, but in the context of CKD, hypocalcemia is largely *driven* by hyperphosphatemia and low Vitamin D levels. [2] * **C. Hypercalcemia:** This is generally not seen in early renal osteodystrophy. It may occur later in **Tertiary Hyperparathyroidism**, where the parathyroid gland becomes autonomous. **Clinical Pearls for NEET-PG:** * **Osteitis fibrosa cystica:** The most common histological finding in renal osteodystrophy (due to high PTH). Look for "Brown tumors" and "dissecting osteitis." * **Rugger-Jersey Spine:** A classic radiological sign of renal osteodystrophy showing subchondral sclerosis. [3] * **FGF-23:** The earliest marker of phosphate metabolism derangement in CKD, rising even before serum phosphate levels exceed normal limits. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Endocrine System, pp. 1106-1107. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Bones, Joints, and Soft Tissue Tumors, pp. 1194-1195. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Osteoarticular And Connective Tissue Disease, pp. 668-669.
Explanation: ### Explanation **Correct Answer: B. Minimal change disease (MCD)** **Why it is correct:** Minimal Change Disease is the most common cause of nephrotic syndrome in children (peak age 2–6 years) [3]. The hallmark of MCD is that the glomeruli appear **normal under Light Microscopy** (hence "minimal change"). However, **Electron Microscopy (EM)** reveals the characteristic **diffuse effacement (fusion) of podocyte foot processes** [1]. Crucially, there are **no electron-dense deposits** (no immune complexes), and Immunofluorescence (IF) is typically negative [2]. The clinical presentation of sudden-onset heavy proteinuria in a young patient with these specific EM findings is diagnostic of MCD. **Why the other options are incorrect:** * **Mesangial proliferative GN:** Characterized by an increase in mesangial cells and matrix on light microscopy, often with IgA or IgG deposits. * **Focal Segmental Glomerulosclerosis (FSGS):** While FSGS also shows foot process effacement, light microscopy would show segmental sclerosis in some (but not all) glomeruli [1]. It is more common in adults and often resistant to steroids [4]. * **Membranous glomerulonephritis:** EM would show characteristic **"subepithelial deposits"** and basement membrane thickening ("spikes and domes"), not just foot process fusion [5]. **High-Yield Clinical Pearls for NEET-PG:** * **Pathogenesis:** T-cell derived cytokine (likely IL-13) causes the loss of the glomerular polyanion (heparan sulfate), leading to **selective proteinuria** (mainly albumin) [2]. * **Treatment:** Excellent response to **Corticosteroids** (Steroid-sensitive) [2]. * **Associations:** In adults, MCD can be associated with **Hodgkin Lymphoma** and NSAID use. * **Lipiduria:** "Maltese cross" appearance of cholesterol esters under polarized light in urine. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Kidney, pp. 927-928. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Kidney, pp. 922-923. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Kidney, pp. 919-921. [4] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Diseases Of The Urinary And Male Genital Tracts, pp. 530-531. [5] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Diseases Of The Urinary And Male Genital Tracts, pp. 531-532.
Explanation: **Explanation:** **Acute Interstitial Nephritis (AIN)** is the classic cause of **eosinophiluria**. AIN is most commonly a drug-induced hypersensitivity reaction (Type I or Type IV) to medications such as NSAIDs, penicillins, sulfonamides, and proton pump inhibitors [1, 2]. The underlying mechanism involves an immune-mediated infiltration of the renal interstitium by inflammatory cells, including T-lymphocytes and eosinophils [1]. These eosinophils eventually shed into the urine, making their presence a highly specific (though not always sensitive) diagnostic marker for AIN. **Why other options are incorrect:** * **Polyarteritis nodosa (PAN):** This is a systemic necrotizing vasculitis of medium-sized arteries. Crucially, PAN **spares the capillaries**, meaning it does not cause glomerulonephritis or significant urinary sediment changes like eosinophiluria. * **Microscopic polyangiitis (MPA):** While MPA involves small vessels and causes necrotizing glomerulonephritis, the urinary sediment typically shows red blood cell (RBC) casts and proteinuria (nephritic syndrome) rather than eosinophils. **High-Yield Clinical Pearls for NEET-PG:** * **Classic Triad of AIN:** Fever, Rash, and Arthralgia (seen in only ~10–30% of patients) [2]. * **Laboratory Findings:** Peripheral eosinophilia, elevated IgE, and eosinophiluria (detected via **Hansel’s stain** or Wright’s stain). * **Other causes of Eosinophiluria:** Atheroembolic renal disease (cholesterol crystals), rapidly progressive glomerulonephritis (RPGN), and prostatitis. * **Gold Standard Diagnosis:** Renal biopsy showing interstitial edema and inflammatory infiltrate [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Kidney, pp. 940-941. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Diseases Of The Urinary And Male Genital Tracts, pp. 538-539.
Explanation: ### Explanation **Correct Option: A. Goodpasture Syndrome** Goodpasture Syndrome is an autoimmune disorder characterized by the presence of **anti-glomerular basement membrane (anti-GBM) antibodies**. These antibodies are directed against the non-collagenous domain of the **α3 chain of Type IV collagen** [1]. Because Type IV collagen is a structural component of both the glomerular basement membrane in the kidneys and the alveolar basement membrane in the lungs, the clinical presentation typically involves a "pulmonary-renal syndrome" consisting of: 1. **Hemoptysis** (due to alveolar hemorrhage) [1]. 2. **Nephritic features/Hematuria** (due to Rapidly Progressive Glomerulonephritis - RPGN). On immunofluorescence, it shows a characteristic **linear deposition** of IgG [1]. **Why other options are incorrect:** * **B. Nephritic Syndrome:** This is a clinical *constellation* (hematuria, hypertension, azotemia, and oliguria) rather than a specific diagnosis. While Goodpasture syndrome presents with nephritic features, the specific triad including hemoptysis and anti-GBM antibodies points specifically to Goodpasture. * **C. Nephrotic Syndrome:** This is characterized by massive proteinuria (>3.5g/day), hypoalbuminemia, and generalized edema. It does not typically present with hemoptysis or anti-GBM antibodies. * **D. Uremic Encephalopathy:** This is a complication of end-stage renal disease (ESRD) resulting from the accumulation of nitrogenous waste, leading to altered mental status. It is not a primary glomerular disease. **NEET-PG High-Yield Pearls:** * **Immunofluorescence:** Linear IgG deposits (Pathognomonic) [1]. * **Light Microscopy:** Presence of **Crescents** (RPGN Type I). * **HLA Association:** Strongly associated with **HLA-DRB1** [1]. * **Treatment:** Plasmapheresis (to remove circulating antibodies) and corticosteroids [1]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Diseases Of The Urinary And Male Genital Tracts, pp. 526-538.
Explanation: **Explanation:** **IgA Nephropathy (Berger’s Disease)** is the most common cause of primary glomerulonephritis worldwide. The correct answer is **D** because the statement is factually incorrect: proteinuria is a common feature of IgA nephropathy, and its absence is certainly not pathognomonic. In fact, persistent heavy proteinuria is a poor prognostic indicator. **Analysis of Options:** * **Option A (Correct Statement):** Light microscopy typically shows **mesangial hypercellularity** and increased matrix [2], [1]. These changes are often **focal and segmental**, though they can progress to global involvement in advanced stages [1]. * **Option B (Correct Statement):** The classic presentation is **recurrent gross hematuria** following an upper respiratory tract infection (synpharyngitic hematuria) [1]. Microscopic hematuria may also be found incidentally. * **Option C (Correct Statement):** Immunofluorescence (IF) is the gold standard for diagnosis. It reveals prominent **mesangial deposits of IgA**, often accompanied by **IgG**, IgM, and C3. * **Option D (Incorrect Statement):** Proteinuria is frequently present [1]. While it is usually in the non-nephrotic range, about 5-10% of patients may develop full-blown nephrotic syndrome. **High-Yield Clinical Pearls for NEET-PG:** * **Pathogenesis:** Associated with **galactose-deficient IgA1** molecules [2]. * **Timing:** Hematuria occurs within 1-2 days of infection (**Synpharyngitic**), unlike Post-Streptococcal Glomerulonephritis (PSGN), which has a 1-3 week lag period [1]. * **Systemic Form:** When IgA nephropathy is associated with systemic vasculitis (purpura, abdominal pain, arthritis), it is known as **Henoch-Schönlein Purpura (HSP)**. * **Prognosis:** The **Oxford Classification (MEST-C score)** is used to predict the risk of progression to chronic kidney disease. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Kidney, pp. 928-929. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Diseases Of The Urinary And Male Genital Tracts, pp. 535-536.
Explanation: **Explanation:** The clinical scenario describes **Tumor Lysis Syndrome (TLS)**, a common complication in patients with high-burden hematologic malignancies (like AML with hyperleukocytosis) following chemotherapy [1]. **Why Option A is correct:** Rapid lysis of tumor cells releases massive amounts of intracellular purines, which are metabolized into **uric acid**. In the presence of **acidic urine**, uric acid precipitates as crystals within the distal tubules and collecting ducts, causing mechanical obstruction and acute kidney injury (AKI) [1]. This is termed **Acute Urate Nephropathy**. **Why the other options are incorrect:** * **Option B (Nephrocalcinosis):** This refers to calcium salt deposition in the renal parenchyma, usually due to chronic hypercalcemia or hyperoxaluria, not acute cell lysis [2]. * **Option C (Leukemic infiltration):** While leukemia can involve the kidneys, it typically causes bilateral renal enlargement and chronic dysfunction rather than sudden oliguric failure immediately following chemotherapy. * **Option D (ATN):** While some chemotherapeutic agents (e.g., Cisplatin) are nephrotoxic, the specific finding of **acidic urine and numerous crystals** strongly points toward urate nephropathy as the primary etiology. **High-Yield Clinical Pearls for NEET-PG:** * **Prophylaxis:** Aggressive hydration and **Allopurinol** (xanthine oxidase inhibitor) or **Rasburicase** (recombinant urate oxidase) are used to prevent TLS [3]. * **Urine pH:** Uric acid is highly insoluble at low pH. Alkalinization of urine (using sodium bicarbonate) helps increase its solubility [1]. * **Microscopy:** Uric acid crystals are typically **pleomorphic** (rhomboid or needle-shaped) and **negatively birefringent** under polarized light. * **Uric Acid/Creatinine Ratio:** A ratio >1.0 in a random urine sample suggests acute urate nephropathy. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Kidney, pp. 941-942. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Diseases Of The Urinary And Male Genital Tracts, pp. 539-540. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Osteoarticular And Connective Tissue Disease, pp. 682-683.
Explanation: **Explanation:** The question tests your understanding of **Secondary (AA) Amyloidosis**, which occurs due to the deposition of Serum Amyloid A (SAA) protein—an acute-phase reactant [1]. This condition is typically associated with **chronic inflammatory states** or chronic infections [2]. **Why Enteric Fever is the correct answer:** Enteric fever (Typhoid) is an **acute** infectious disease caused by *Salmonella typhi* [2]. Because it is a self-limiting or acutely treated infection, it does not provide the prolonged, chronic inflammatory stimulus required for the liver to produce sustained high levels of SAA protein. Therefore, it does not lead to amyloid deposition. **Analysis of incorrect options (Conditions that DO cause Amyloidosis):** * **Ulcerative Colitis:** This is a chronic inflammatory bowel disease (IBD). Persistent inflammation of the colonic mucosa triggers chronic elevation of SAA, leading to AA amyloidosis [2]. * **Suppurative Lung Disease:** Conditions like bronchiectasis, chronic lung abscesses, and empyema are classic causes of secondary amyloidosis due to long-standing pyogenic infection [1]. * **Hansen’s Disease (Leprosy):** Specifically, the lepromatous form and chronic "Type 2 reactions" (Erythema Nodosum Leprosum) are well-documented causes of renal amyloidosis in endemic regions. **High-Yield Clinical Pearls for NEET-PG:** * **Most common organ involved in systemic amyloidosis:** Kidney (presents as nephrotic syndrome) [1]. * **Staining:** Amyloid shows **Apple-green birefringence** under polarized light with **Congo Red** stain. * **AA Amyloidosis:** Associated with chronic infections (TB, Osteomyelitis, Leprosy) and chronic inflammation (Rheumatoid Arthritis - most common cause in the West, IBD) [1], [2]. * **AL Amyloidosis:** Associated with Multiple Myeloma (Plasma cell dyscrasias) [3]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 136-140. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 195-196. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Kidney, pp. 942-943.
Explanation: **Explanation:** Nephrotic syndrome is characterized by massive proteinuria (>3.5 g/day), hypoalbuminemia, edema [1], and hyperlipidemia [3]. The correct answer is **Low serum calcium** due to the following mechanisms: 1. **Hypoalbuminemia:** Approximately 40-50% of serum calcium is bound to albumin. In nephrotic syndrome, the profound loss of albumin leads to a decrease in the **total serum calcium** level [1]. However, the physiologically active ionized calcium usually remains normal. 2. **Vitamin D Deficiency:** Patients lose **Vitamin D-binding protein** in the urine. This results in low levels of 25-hydroxyvitamin D, leading to decreased intestinal calcium absorption and further contributing to hypocalcemia. **Analysis of Incorrect Options:** * **B. Raised antithrombin III:** Incorrect. Nephrotic syndrome is a **hypercoagulable state** because low-molecular-weight anticoagulants like **Antithrombin III**, Protein C, and Protein S are **lost in the urine**, not raised. * **C. Low lipids:** Incorrect. **Hyperlipidemia** is a hallmark of nephrotic syndrome [3]. Hypoalbuminemia triggers the liver to increase the synthesis of lipoproteins (VLDL, LDL) to maintain oncotic pressure. * **D. Platelet activation:** While platelet aggregation can be increased in nephrotic syndrome (contributing to thrombosis), it is a secondary feature. In the context of standard NEET-PG questions, the biochemical hallmark remains the metabolic disturbances like hypocalcemia. **High-Yield Clinical Pearls for NEET-PG:** * **Most common cause** of Nephrotic Syndrome in children: Minimal Change Disease (MCD) [2], [3]. * **Hypercoagulability:** Renal Vein Thrombosis is most commonly associated with **Membranous Nephropathy** [3]. * **Urinary finding:** "Maltese cross" appearance under polarized microscopy due to lipiduria (oval fat bodies). **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 126-127. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Kidney, pp. 922-923. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Kidney, pp. 919-921.
Explanation: **Explanation:** Hemolytic Uremic Syndrome (HUS) is a clinical triad characterized by **Microangiopathic Hemolytic Anemia (MAHA)**, **Thrombocytopenia**, and **Acute Kidney Injury (AKI)** [1]. It is a form of Thrombotic Microangiopathy (TMA) [2]. 1. **Thrombocytopenia (Option A):** In HUS, widespread formation of microthrombi in the small vessels (especially in the kidneys) leads to the excessive consumption of platelets, resulting in a low platelet count [3]. 2. **Schistocytes (Option B):** As Red Blood Cells (RBCs) attempt to pass through capillaries partially occluded by fibrin-platelet meshworks, they undergo mechanical shearing [2]. This fragmentation produces **schistocytes** (helmet cells) seen on a peripheral blood smear, a hallmark of MAHA. 3. **E. coli (Option C):** The most common form (Typical HUS) is caused by **Shiga toxin-producing Escherichia coli (STEC)**, specifically the **O157:H7** serotype [1]. The toxin damages glomerular endothelial cells, triggering the pro-thrombotic state. Since all three features are defining characteristics of the disease, **Option D** is the correct answer. **High-Yield Clinical Pearls for NEET-PG:** * **Typical HUS:** Preceded by bloody diarrhea (Dysentery). * **Atypical HUS:** Associated with mutations in **Complement Factor H** or other regulatory proteins (Factor I, Membrane Cofactor Protein) [1]. * **Pathology:** On light microscopy, "wire-loop" like thickening of capillary walls and **subendothelial electron-lucent deposits** (fluff) are seen on Electron Microscopy. * **Treatment:** Supportive care for typical HUS; **Eculizumab** (anti-C5 antibody) is the drug of choice for Atypical HUS. * **Differential:** Unlike TTP (Thrombotic Thrombocytopenic Purpura), HUS usually lacks prominent neurological symptoms and is not primarily caused by ADAMTS13 deficiency [4]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Kidney, pp. 946-947. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Diseases Of The Urinary And Male Genital Tracts, pp. 540-541. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Red Blood Cell and Bleeding Disorders, pp. 667-668. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Kidney, pp. 947-948.
Explanation: **Explanation:** Bladder cancer (Urothelial/Transitional Cell Carcinoma) follows two distinct genetic pathways: the **papillary (low-grade) pathway** and the **non-papillary (high-grade/carcinoma in situ) pathway** [2]. **1. Why FGFR3 is correct:** Low-grade papillary urothelial carcinomas are characterized by gain-of-function mutations in the **FGFR3 (Fibroblast Growth Factor Receptor 3)** gene located on chromosome 4p16. This mutation leads to constitutive activation of the receptor tyrosine kinase, promoting cell proliferation. Approximately 70-80% of low-grade non-invasive papillary tumors harbor this mutation, making it a hallmark of stable, low-grade disease. **2. Why the other options are incorrect:** * **p53 (TP53) & Rb gene:** Mutations in these tumor suppressor genes are characteristic of the **high-grade pathway**. They are typically found in Carcinoma in Situ (CIS) and invasive high-grade urothelial carcinomas [2]. Loss of p53/Rb function leads to genomic instability and aggressive clinical behavior. * **HRAS:** While HRAS mutations can occur in bladder cancer (often as an alternative to FGFR3 in the RAS-MAPK pathway), they are less frequent than FGFR3 mutations in low-grade tumors. **3. NEET-PG High-Yield Pearls:** * **Field Cancerization:** The entire urothelium is exposed to carcinogens (e.g., cigarette smoke, naphthylamine), leading to multifocal tumors [2]. * **Schistosoma haematobium:** Associated specifically with **Squamous Cell Carcinoma** of the bladder, not TCC. * **Chromosome 9 deletions:** These are the most common initial events in both pathways of bladder cancer (9p and 9q deletions). * **Treatment Tip:** Low-grade tumors have a high recurrence rate but low progression rate; high-grade tumors carry a high risk of invasion and metastasis [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lower Urinary Tract and Male Genital System, p. 970. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Diseases Of The Urinary And Male Genital Tracts, pp. 495-496.
Congenital Anomalies of the Kidney
Practice Questions
Glomerular Diseases
Practice Questions
Tubular and Interstitial Diseases
Practice Questions
Vascular Diseases of the Kidney
Practice Questions
Cystic Diseases of the Kidney
Practice Questions
Urinary Tract Obstruction and Stones
Practice Questions
Renal Tumors
Practice Questions
Kidney in Systemic Diseases
Practice Questions
Renal Transplantation Pathology
Practice Questions
Urinary Tract Infections
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free